Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Effect of Iron Isomaltoside on Skeletal Muscle Energetics in Patients With Chronic Heart Failure and Iron Deficiency
Geoff Charles‐Edwards, Nelson Amaral, Alison Sleigh, et al.
Circulation (2019) Vol. 139, Iss. 21, pp. 2386-2398
Open Access | Times Cited: 126

Showing 26-50 of 126 citing articles:

Pharmacotherapy for heart failure with reduced ejection fraction and health‐related quality of life: a systematic review and meta‐analysis
Ricky D. Turgeon, Arden R. Barry, Nathaniel M. Hawkins, et al.
European Journal of Heart Failure (2021) Vol. 23, Iss. 4, pp. 578-589
Open Access | Times Cited: 34
A systematic literature review and meta-analysis of the incidence of serious or severe hypersensitivity reactions after administration of ferric derisomaltose or ferric carboxymaltose
Nicholas A. Kennedy, Maureen M. Achebe, Patrick Biggar, et al.
International Journal of Clinical Pharmacy (2023) Vol. 45, Iss. 3, pp. 604-612
Open Access | Times Cited: 14
Identification of three mechanistic pathways for iron-deficient heart failure
Milton Packer, Stefan D. Anker, Javed Butler, et al.
European Heart Journal (2024) Vol. 45, Iss. 26, pp. 2281-2293
Open Access | Times Cited: 6
Treating iron deficiency in patients with heart failure: what, why, when, how, where and who
Fraser J Graham, Kaushik Guha, John G.F. Cleland, et al.
Heart (2024) Vol. 110, Iss. 20, pp. 1201-1207
Open Access | Times Cited: 5
Anaemia predicts iron homoeostasis dysregulation and modulates the response to empagliflozin in heart failure with reduced ejection fraction: the EMPATROPISM-FE trial
Christiane E. Angermann, Susanne Sehner, Louisa M.S. Gerhardt, et al.
European Heart Journal (2024)
Open Access | Times Cited: 5
Mendelian randomisation analysis of red cell distribution width in pulmonary arterial hypertension
Anna Ulrich, John Wharton, Timothy E. Thayer, et al.
European Respiratory Journal (2019) Vol. 55, Iss. 2, pp. 1901486-1901486
Open Access | Times Cited: 37
Additional burden of iron deficiency in heart failure patients beyond the cardio‐renal anaemia syndrome: findings from the BIOSTAT‐CHF study
Ridha I.S. Alnuwaysir, Niels Grote Beverborg, Martijn F. Hoes, et al.
European Journal of Heart Failure (2021) Vol. 24, Iss. 1, pp. 192-204
Open Access | Times Cited: 30
Iron Deficiency without Anemia Decreases Physical Endurance and Mitochondrial Complex I Activity of Oxidative Skeletal Muscle in the Mouse
Emmanuel Rineau, Naïg Guéguen, Vincent Procaccio, et al.
Nutrients (2021) Vol. 13, Iss. 4, pp. 1056-1056
Open Access | Times Cited: 28
Systematic review and meta‐analysis of intravenous iron‐carbohydrate complexes in HFrEF patients with iron deficiency
Andrew Sindone, Wolfram Doehner, Josep Comín‐Colet
ESC Heart Failure (2022) Vol. 10, Iss. 1, pp. 44-56
Open Access | Times Cited: 22
Comprehensive evaluation of the possible impact of roofing materials on the quality of harvested rainwater for human consumption
Briana Mwinkom Tengan, Osei Akoto
The Science of The Total Environment (2022) Vol. 819, pp. 152966-152966
Closed Access | Times Cited: 21
Cardiac energetics in patients with chronic heart failure and iron deficiency: an in‐vivo 31P magnetic resonance spectroscopy study
Francesco Papalia, Fadi Jouhra, George Amin‐Youssef, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 4, pp. 716-723
Open Access | Times Cited: 20
Intravenous iron therapy improves the hypercapnic ventilatory response and sleep disordered breathing in chronic heart failure
Sergio Caravita, Andrea Faini, Carlo Vignati, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 10, pp. 1940-1949
Open Access | Times Cited: 20
Pre-emptive iron supplementation prevents myocardial iron deficiency and attenuates adverse remodelling after myocardial infarction
Bomee Chung, Yong Wang, Marleen Thiel, et al.
Cardiovascular Research (2023) Vol. 119, Iss. 10, pp. 1969-1980
Closed Access | Times Cited: 12
Is myocardial accumulation of non-transferrin-bound iron clinically relevant?
Stephan von Haehling, Ryosuke Sato, Stefan D. Anker
European Heart Journal (2024) Vol. 45, Iss. 42, pp. 4509-4511
Open Access | Times Cited: 4
A multicentre prospective double blinded randomised controlled trial of intravenous iron (ferric Derisomaltose (FDI)) in Iron deficient but not anaemic patients with chronic kidney disease on functional status
Sunil Bhandari, Victoria Allgar, Archie Lamplugh, et al.
BMC Nephrology (2021) Vol. 22, Iss. 1
Open Access | Times Cited: 26
The effect of intravenous ferric carboxymaltose on right ventricular function – insights from the IRON‐CRT trial
Pieter Martens, Matthias Dupont, Jeroen Dauw, et al.
European Journal of Heart Failure (2022) Vol. 24, Iss. 6, pp. 1106-1113
Open Access | Times Cited: 18
Hepcidin, Incident Heart Failure and Cardiac Dysfunction in Older Adults: the ARIC Study
Iman Aboelsaad, Brian Claggett, Victoria Arthur, et al.
European Journal of Preventive Cardiology (2025)
Closed Access
Physicochemical Characteristics of Cardiological Drugs and Practical Recommendations for Intravenous Administration: A Systematic Review
Massimiliano Quici, Elena Martini, Davide Giustivi, et al.
Scientia Pharmaceutica (2025) Vol. 93, Iss. 1, pp. 13-13
Open Access
Diagnosis and treatment of iron deficiency in chronic heart failure
Moritz Messner, Gerhard Pölzl, Christopher Adlbrecht, et al.
Wiener klinische Wochenschrift (2025) Vol. 137, Iss. S3, pp. 143-156
Open Access
Intravenous iron therapy for non-anaemic, iron-deficient adults
Lachlan F. Miles, Edward Litton, Georgina Imberger, et al.
Cochrane library (2019)
Open Access | Times Cited: 29
How I treat anemia in heart failure
Inder S. Anand, Pankaj Gupta
Blood (2020) Vol. 136, Iss. 7, pp. 790-800
Open Access | Times Cited: 27
Improving the safety of intravenous iron treatments for patients with chronic kidney disease
Xenophon Kassianides, Adil M. Hazara, Sunil Bhandari
Expert Opinion on Drug Safety (2020) Vol. 20, Iss. 1, pp. 23-35
Closed Access | Times Cited: 27
Iron Deficiency in CKD Without Concomitant Anemia
Jay B. Wish, Stefan D. Anker, Javed Butler, et al.
Kidney International Reports (2021) Vol. 6, Iss. 11, pp. 2752-2762
Open Access | Times Cited: 23
Iron Deficiency Is Associated With Impaired Biventricular Reserve and Reduced Exercise Capacity in Patients With Unexplained Dyspnea
Pieter Martens, Guido Claessen, Alexander Van De Bruaene, et al.
Journal of Cardiac Failure (2021) Vol. 27, Iss. 7, pp. 766-776
Closed Access | Times Cited: 21
Safety and Efficacy of Intravenous Ferric Derisomaltose Compared to Iron Sucrose for Iron Deficiency Anemia in Patients with Chronic Kidney Disease With and Without Heart Failure
Andrew P. Ambrosy, Stephan von Haehling, Paul R. Kalra, et al.
The American Journal of Cardiology (2021) Vol. 152, pp. 138-145
Open Access | Times Cited: 21

Scroll to top